scholarly journals Patient-health care professional gender or race/ethnicity concordance and its association with weight-related advice in the United States

2016 ◽  
Vol 99 (2) ◽  
pp. 271-278 ◽  
Author(s):  
Hsing-Yu Yang ◽  
Hsin-Jen Chen ◽  
Jill A. Marsteller ◽  
Lan Liang ◽  
Leiyu Shi ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Health Care Professional ◽  
The United States ◽  
Patient Health ◽  
Race Ethnicity

scholarly journals An Opportunity for Pharmacists to Help Improve Coordination and Continuity of Patient Health Care

Pharmacy ◽  
2018 ◽  
Vol 6 (3) ◽  
pp. 78 ◽  
Author(s):  
Jon Schommer ◽  
Lawrence Brown ◽  
Ryan Bortz ◽  
Alina Cernasev ◽  
Basma Gomaa ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Health Care System ◽  
Medication Use ◽  
The United States ◽  
Patient Health ◽  
Consumer Perspective ◽  
Medication Experience ◽  
Pharmacist Workforce ◽  
Care System

Pharmacist workforce researchers are predicting a potential surplus of pharmacists in the United States that might result in pharmacists being available for engagement in new roles. The objective for this study was to describe consumer opinions regarding medication use, the health care system, and pharmacists to help identify new roles for pharmacists from the consumer perspective. Data were obtained from the 2015 and 2016 National Consumer Surveys on the Medication Experience and Pharmacist Roles. Out of the representative sample of 36,673 respondents living in the United States, 80% (29,426) submitted written comments at the end of the survey. Of these, 2178 were specifically about medicines, pharmacists or health and were relevant and usable for this study. Thematic analysis, content analysis, and computer-based text mining were used for identifying themes and coding comments. The findings showed that 66% of the comments about medication use and 82% about the health care system were negative. Regarding pharmacists, 73% of the comments were positive with many commenting about the value of the pharmacist for overcoming fears and for filling current gaps in their healthcare. We propose that these comments might be signals that pharmacists could help improve coordination and continuity for peoples’ healthcare and could help guide the development of new service offerings.

scholarly journals Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups

Hypertension ◽  
2021 ◽  
Author(s):  
Brent M. Egan ◽  
Jiexiang Li ◽  
Susan E. Sutherland ◽  
Michael K. Rakotz ◽  
Gregory D. Wozniak
Keyword(s):  
United States ◽  
Blood Pressure ◽  
Health Care ◽  
Access To Care ◽  
Odds Ratio ◽  
Treatment Effectiveness ◽  
The United States ◽  
Hypertension Control ◽  
Race Ethnicity ◽  
Hispanic White

Hypertension control (United States) increased from 1999 to 2000 to 2009 to 2010, plateaued during 2009 to 2014, then fell during 2015 to 2018. We sought explanatory factors for declining hypertension control and assessed whether specific age (18–39, 40–59, ≥60 years) or race-ethnicity groups (Non-Hispanic White, NH [B]lack, Hispanic) were disproportionately impacted. Adults with hypertension in National Health and Nutrition Examination Surveys during the plateau (2009–2014) and decline (2015–2018) in hypertension control were studied. Definitions: hypertension, blood pressure (mm Hg) ≥140 and/or ≥90 mm Hg or self-reported antihypertensive medications (Treated); Aware, ‘Yes” to, “Have you been told you have hypertension?”; Treatment effectiveness, proportion of treated adults controlled; control, blood pressure <140/<90. Comparing 2009 to 2014 to 2015 to 2018, blood pressure control fell among all adults (−7.5% absolute, P <0.001). Hypertension awareness (−3.4%, P =0.01), treatment (−4.6%, P =0.004), and treatment effectiveness (−6.0%, P <0.0001) fell, despite unchanged access to care (health care insurance, source, and visits [−0.2%, P =0.97]). Antihypertensive monotherapy rose (+4.2%, P =0.04), although treatment resistance factors increased (obesity +4.0%, P =0.02, diabetes +2.3%, P =0.02). Hypertension control fell across age (18–39 [−4.9%, P =0.30]; 40–59 [−9.9%, P =0.0003]; ≥60 years [−6.5%, P =0.005]) and race-ethnicity groups (Non-Hispanic White [−8.5%, P =0.0007]; NHB −7.4%, P =0.002]; Hispanic [−5.2%, P =0.06]). Racial/ethnic disparities in hypertension control versus Non-Hispanic White were attenuated after adjusting for modifiable factors including education, obesity and access to care; NHB (odds ratio, 0.79 unadjusted versus 0.84 adjusted); Hispanic (odds ratio 0.74 unadjusted versus 0.98 adjusted). Improving hypertension control and reducing disparities require greater and more equitable access to high quality health care and healthier lifestyles.

The Compounding Effect of Race/Ethnicity and Disability Status on Children’s Health and Health Care by Geography in the United States

Medical Care ◽  
2020 ◽  
Vol 58 (12) ◽  
pp. 1059-1068
Author(s):  
Ilhom Akobirshoev ◽  
Monika Mitra ◽  
Frank S. Li ◽  
Robert Dembo ◽  
Dan Dooley ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
The United States ◽  
Children's Health ◽  
Children’S Health ◽  
Disability Status ◽  
Race Ethnicity

scholarly journals A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018

2020 ◽  
Vol 135 (1_suppl) ◽  
pp. 100S-127S ◽  
Author(s):  
Bahareh Ansari ◽  
Katherine M. Tote ◽  
Eli S. Rosenberg ◽  
Erika G. Martin
Keyword(s):  
United States ◽  
Health Care ◽  
Health Care Provider ◽  
Care Provider ◽  
The United States ◽  
Health Insurer ◽  
Pain Clinic ◽  
Rapid Review ◽  
Opioid Use ◽  
Patient Health

Objectives In the United States, rising rates of overdose deaths and recent outbreaks of hepatitis C virus and HIV infection are associated with injection drug use. We updated a 2014 review of systems-level opioid policy interventions by focusing on evidence published during 2014-2018 and new and expanded opioid policies. Methods We searched the MEDLINE database, consistent with the 2014 review. We included articles that provided original empirical evidence on the effects of systems-level interventions on opioid use, overdose, or death; were from the United States or Canada; had a clear comparison group; and were published from January 1, 2014, through July 19, 2018. Two raters screened articles and extracted full-text data for qualitative synthesis of consistent or contradictory findings across studies. Given the rapidly evolving field, the review was supplemented with a search of additional articles through November 17, 2019, to assess consistency of more recent findings. Results The keyword search yielded 535 studies, 66 of which met inclusion criteria. The most studied interventions were prescription drug monitoring programs (PDMPs) (59.1%), and the least studied interventions were clinical guideline changes (7.6%). The most common outcome was opioid use (77.3%). Few articles evaluated combination interventions (18.2%). Study findings included the following: PDMP effectiveness depends on policy design, with robust PDMPs needed for impact; health insurer and pharmacy benefit management strategies, pill-mill laws, pain clinic regulations, and patient/health care provider educational interventions reduced inappropriate prescribing; and marijuana laws led to a decrease in adverse opioid-related outcomes. Naloxone distribution programs were understudied, and evidence of their effectiveness was mixed. In the evidence published after our search’s 4-year window, findings on opioid guidelines and education were consistent and findings for other policies differed. Conclusions Although robust PDMPs and marijuana laws are promising, they do not target all outcomes, and multipronged interventions are needed. Future research should address marijuana laws, harm-reduction interventions, health insurer policies, patient/health care provider education, and the effects of simultaneous interventions on opioid-related outcomes.

The Role of Income and Race/Ethnicity in Experiences with Medical Care in the United States and United Kingdom

2008 ◽  
Vol 38 (4) ◽  
pp. 671-695 ◽  
Author(s):  
Jason Schnittker ◽  
Mehul Bhatt
Keyword(s):  
United States ◽  
Primary Care ◽  
Health Care ◽  
United Kingdom ◽  
Health Insurance ◽  
Medical Care ◽  
Health Care Systems ◽  
The United States ◽  
System Level ◽  
Race Ethnicity

Inequalities in experiences with medical care are well-known in the United States, but little is known about the shape of such inequalities in other countries. This study compares a broad spectrum of experiences in the United States and United Kingdom. Furthermore, it focuses on two of the most important dimensions of inequality, race/ethnicity and income, and two of the most widely discussed system-level factors, health insurance and emphasis on primary care. Two general conclusions are reached. First, there are broad income-based inequalities in medical care in both the United States and United Kingdom. These inequalities persist even after controlling for health insurance, including private medical insurance in the United Kingdom. Race is also related to experiences with medical care, although the effects of race are more particular and contingent than are those for income. In particular, the mapping of racial/ethnic inequality differs considerably between the United States and United Kingdom, reflecting their different sociocultural climates. Second, the health care system, especially primary care, plays a limited role in ameliorating inequalities in care, but plays a strong role in elevating the average level of quality within a country. Because inequalities in medical care reflect broader social processes, they are durable across very different health care systems and contexts.

Barriers to Health Care Among Adults With Minoritized Identities in the United States, 2013–2017

2020 ◽  
Vol 110 (6) ◽  
pp. 857-862
Author(s):  
Stephanie M. Hernandez ◽  
P. Johnelle Sparks
Keyword(s):  
United States ◽  
Health Care ◽  
Access To Health Care ◽  
The United States ◽  
Barriers To Health Care ◽  
Access To Health ◽  
Interview Survey ◽  
Race Ethnicity ◽  
Nationally Representative ◽  
Barriers To Health

Objectives. To examine the relationship between minoritized identity and barriers to health care in the United States. Methods. Nationally representative data collected from the 2013 to 2017 waves of the National Health Interview Survey were used to conduct descriptive and logistic regression analyses. Men and women were placed in 1 of 4 categories: no minoritized identities, minoritized identities of race/ethnicity (MIoRE), minoritized identities of sexuality (MIoS), or minoritized identities of both race/ethnicity and sexuality (MIoRES). Five barriers to health care were considered. Results. Relative to heterosexual White adults and after controlling for socioeconomic status, adults with MIoRE were less likely to report barriers, adults with MIoS were more likely to report barriers, and adults with MIoRES were more likely to report barriers across 2 of the study measures. Conclusions. Barriers to care varied according to gender, minoritized identity, and the measure of access to health care itself. Public Health Implications. Approaching health disparities research using an intersectional lens moves the discussion from examining individual differences to examining the role of social structures such as the health care system in maintaining and reproducing inequality.

scholarly journals Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States

Pharmacy ◽  
2019 ◽  
Vol 7 (3) ◽  
pp. 106 ◽  
Author(s):  
Jean-Venable Goode ◽  
James Owen ◽  
Alexis Page ◽  
Sharon Gatewood
Keyword(s):  
United States ◽  
Health Care ◽  
Patient Care ◽  
Pharmacy Practice ◽  
The United States ◽  
Community Based ◽  
Care Services ◽  
Patient Health

Community-based pharmacy practice is evolving from a focus on product preparation and dispensing to becoming a health care destination within the four walls of the traditional community-based pharmacy. Furthermore, community-based pharmacy practice is expanding beyond the four walls of the traditional community-based pharmacy to provide care to patients where they need it. Pharmacists involved in this transition are community-based pharmacist practitioners who are primarily involved in leading and advancing team-based patient care services in communities to improve the patient health. This paper will review community-based pharmacy practice innovations and the role of the community-based pharmacist practitioner in the United States.

scholarly journals PIH82 Health Care Screening and Preventive Practices among Women in the United States by Race/Ethnicity

2012 ◽  
Vol 15 (4) ◽  
pp. A206
Author(s):  
M. McDonald ◽  
F.D. Pickart ◽  
J. Zhou ◽  
J. Mardekian
Keyword(s):  
United States ◽  
Health Care ◽  
The United States ◽  
Preventive Practices ◽  
Race Ethnicity
Sign in / Sign up

Export Citation Format

Share Document